RESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for RESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to wipe out liver cancer before surgeons even operate
Disease control OngoingThis study is testing whether giving two immunotherapy drugs before surgery can help people with operable liver cancer. The drugs, atezolizumab and bevacizumab, aim to help the body's immune system attack the cancer and cut off its blood supply. Researchers hope this pre-surgery …
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New combo therapy aims to boost immune system against liver cancer before surgery
Disease control OngoingThis is a small, early-stage study testing a new treatment approach for liver cancer that can be removed by surgery. Researchers want to see if giving a combination of targeted radiation and two immunotherapy drugs *before* the operation is safe and might help the body's immune s…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC